Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
Clinical trial NCT01478633 · COMPLETED
Trial details
- NCT number
- NCT01478633
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.